Year: 2024

18811 posts

Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List

SHANGHAI, Nov. 28, 2024 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, "Everest", or…

Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country

SHANGHAI and HONG KONG, Nov. 28, 2024 /PRNewswire/ — Antengene Corporation Limited…
ASSEMBLY ELEVATES VIVIAN MOK TO SVP & MANAGING DIRECTOR FOR NORTH ASIA

ASSEMBLY ELEVATES VIVIAN MOK TO SVP & MANAGING DIRECTOR FOR NORTH ASIA

Mok will be pivotal in solidifying Assembly’s proposition and accelerating the agency’s…

Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List

SAN FRANCISCO and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ — Innovent Biologics,…
Team T5 Applauded by Frost & Sullivan for Deeply and Effectively Monitoring Regional Adversaries and Incidents

Team T5 Applauded by Frost & Sullivan for Deeply and Effectively Monitoring Regional Adversaries and Incidents

With offices in Taiwan and Japan, TeamT5 provides in-depth localized threat intelligence,…

Akeso Announced the Inclusion in China's National Reimbursement Drug List of Cadonilimab and Ivonescimab

HONG KONG, Nov. 28, 2024 /PRNewswire/ — Akeso, Inc. (9926. HK) ("Akeso"…
Hangzhou Hosts Second Liangzhu Forum with Global Cultural Leaders

Hangzhou Hosts Second Liangzhu Forum with Global Cultural Leaders

HANGZHOU, China, Nov. 28, 2024 /PRNewswire/ — The Second Liangzhu Forum, an…

Global Times: Dialogue across Yangtze, Rhine, Danube bridges mutual learning between China and Europe

BEIJING, Nov. 28, 2024 /PRNewswire/ — When Chinese scholar Li Xiuzhen first saw…